Veradigm Inc.

Veradigm Inc. is a healthcare technology company that provides clinical, financial, and analytical solutions to various stakeholders within the healthcare ecosystem. Headquartered in Chicago, Illinois, U.S., the company's mission is to improve healthcare outcomes through innovative technology solutions and to empower the healthcare community to advance patient care. It operates primarily through the Veradigm Network, which leverages platforms, data, expertise, connectivity, and scale to drive value.

Veradigm's key offerings include practice management and electronic health record (EHR) technology, patient engagement tools, care coordination solutions, and financial and analytics technology. The company provides a full spectrum of revenue cycle services, including coding, billing, collections, and claims management, and offers solutions like e-prescribing, gap closure alerts, and AI-powered patient scheduling. Its market segments encompass healthcare providers (physician practices, hospitals, and extended care organizations), life sciences organizations (such as pharmaceutical companies), and payers (health insurance companies).

Formerly known as Allscripts Healthcare Solutions, Inc., the company formally changed its name to Veradigm Inc. in January 2023. Veradigm was delisted from Nasdaq in February 2024 and now trades on the OTC Markets under the ticker MDRX, following non-compliance with listing rules related to financial reporting. The company is actively working to become current in its SEC filings and aims for relisting on Nasdaq by the end of 2026. Recent leadership changes include Tom Langan assuming the role of interim CEO in June 2024 and Christian Greyenbuhl being appointed CFO effective May 2026. Veradigm continues to focus on AI-enabled solutions, such as Veradigm Ambient Scribe, and initiatives for real-world evidence generation.

Latest updates

Veradigm Wins KLAS Award for SDOH Data Integration, Signaling Shift in Value-Based Care

  • Veradigm received the 2026 KLAS Points of Light Award for embedding social determinants of health (SDOH) data into provider EHR workflows.
  • The initiative involved Veradigm, a national health plan with 27 million members, and Raleigh Durham Medical Group.
  • The project utilized Veradigm’s Payer Insights (VPI) platform to deliver SDOH-triggered clinical reminders and connect providers to referral networks.
  • The collaboration resulted in improved care gap closure rates and a FHIR-aligned, scalable model for payer-provider interoperability.

The KLAS award highlights a growing recognition of the need to integrate SDOH data into clinical workflows to improve patient outcomes and manage costs within value-based care models. Veradigm’s solution addresses a critical bottleneck – the lack of timely access to SDOH data for clinicians – and positions the company to capitalize on the increasing demand for interoperable data solutions within the healthcare ecosystem. The initiative’s success could accelerate the adoption of similar models across the fragmented US healthcare landscape.

Adoption Rate
The success of Veradigm’s model hinges on broader adoption by independent practices and health plans, which will require demonstrating clear ROI beyond the initial pilot.
FHIR Scalability
While the FHIR-aligned architecture promises scalability, the real test will be maintaining data integrity and interoperability as the system expands across diverse EHR systems and payers.
Regulatory Risk
Increased scrutiny of SDOH data usage and privacy could impact Veradigm’s ability to leverage this data, necessitating ongoing compliance efforts and potentially limiting the scope of its services.

Veradigm Bets Big on India, Doubles Workforce and Appoints New Leader

  • Veradigm is doubling the size of its Pune, India operations, expanding office capacity by roughly 100%.
  • The company has appointed Divesh Singla as Managing Director, India Operations, effective immediately.
  • Singla brings over 20 years of experience in global operations across India and Southeast Asia.
  • Veradigm cites a 'AI-fueled global workforce' as a key growth lever.
  • The expansion is intended to support scale, collaboration, and employee wellbeing.

Veradigm’s investment in India underscores the growing importance of offshore operations for US-based healthcare technology providers seeking to leverage lower labor costs and access a large pool of skilled workers. This expansion aligns with a broader trend of companies building AI-powered global workforces to support 24/7 operations and enhance service delivery. The appointment of Singla signals a commitment to making India a core engine for Veradigm's global growth, but also introduces execution risk associated with integrating a rapidly expanded team and technology base.

Execution Risk
The success of Veradigm’s India strategy hinges on Singla’s ability to integrate the expanded team and technology capabilities effectively, particularly given his mandate to scale talent and build a high-performing organization.
Cost Structure
Doubling the workforce and expanding facilities will significantly increase Veradigm’s operating expenses in India; the company will need to demonstrate a clear return on this investment to justify the increased cost structure.
Talent Competition
Pune’s emergence as a tech hub means Veradigm will face increased competition for skilled professionals, potentially impacting retention and driving up labor costs.
CID: 1732